SCHEMBL9944918

SCHEMBL9944918

CCOC(=O)c1cc(N)c(NC)cc1N1CC2COCC2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
LMNA P02545 3/20 0.39
PTGER4 P35408 2/20 0.38
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 2/20 0.36
GAA P10253 4/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
MAPT P10636 4/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
TNNI3 P19429 1/20 0.35
CASP1 P29466 1/20 0.35
BRCA1 P38398 1/20 0.35
TNNT2 P45379 1/20 0.35
CASP7 P55210 1/20 0.35
TNNC1 P63316 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944861 0.91 ALDH1A1 (0.41) ALDH1A1L3MBTL1LMNAPTGER4ALOX15
SCHEMBL9944865 0.84 LMNA (0.49) ALDH1A1L3MBTL1LMNAHSD17B10GAA
SCHEMBL9944921 0.83 ALDH1A1 (0.47) ALDH1A1LMNAPTGER4KDM4EHPGD
SCHEMBL9944760 0.81 ALDH1A1 (0.47) ALDH1A1L3MBTL1LMNAPTGER4ALOX15
SCHEMBL9944869 0.78 ALDH1A1 (0.42) ALDH1A1L3MBTL1LMNAHSD17B10GAA
SCHEMBL9897728 0.78 ALDH1A1 (0.40) ALDH1A1L3MBTL1LMNAPTGER4ALOX15
SCHEMBL25304306 0.75 KDM4E (0.43) ALDH1A1L3MBTL1LMNAHSD17B10GAA
SCHEMBL9944762 0.74 GAA (0.51) ALDH1A1L3MBTL1LMNAHSD17B10GAA
SCHEMBL9944859 0.74 ALDH1A1 (0.48) ALDH1A1LMNAPTGER4KDM4EHPGD
SCHEMBL1964928 0.72 ALDH1A1 (0.46) ALDH1A1L3MBTL1LMNAPTGER4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed
WO-2012076673-A1 6-AMINO-2-PHENYLAMINO-1H-BENZIMIDAZOLE-5-CARBOXAMIDE- DERIVATIVES AND THEIR USE AS MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885L3MBTL1 3016/4885LMNA 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.